Literature DB >> 8842749

Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.

K Matsuzaki1, M Kan, W L McKeehan.   

Abstract

Two transmembrane serine-threonine kinases (type I and II receptors), a membrane-anchored proteoglycan (type III), and a homodimeric ligand participate in the transforming growth factor beta type one (TGF beta 1) signal transduction complex. The expression of recombinant receptors in insect cells co-infected with up to three recombinant baculoviruses was employed to study interactions among the ectodomains of the three types of receptors and the TGF beta 1 ligand in absence of uncontrollable extrinsic factors in mammalian cells. Multi-subunit complexes were assembled in intact cells and purified on glutathione-conjugated beads for analysis by tagging one of the subunits with glutathione S-transferase (GST). Intrinsic ligand-independent interactions were observed among receptor subunits as follows: type III-III, type I-I, type III-I, and type II-I. The homeotypic complex of type II-II receptors and the heterotypic type III-II interaction was ligand dependent. The type I, but not the type III, subunit displaced about 50% of the type II component in either ligand-dependent homomeric type II-type II complexes or heteromeric type III-type II complexes to form type II-I or type III-II-I oligomers, respectively. The type II subunit displaced type I subunits in oligomers of the type I subunit. Specificity of type I receptors may result from differential affinity for the type II receptor rather than specificity for ligand. A monomeric subunit of the TGF beta 1 ligand bound concurrently to type III and type II or type III and type I receptors, but failed to concurrently bind to the type II and type I subunits. The binding of TGF beta 1 to the type I kinase subunit appears to require an intact disulfide-linked ligand dimer in the absence of a type III subunit. The combined results suggest a pentameric TGF beta signal transduction complex in which one unit each of the type III, type II, and type I components is assembled around the two subunits of the dimeric TGF beta ligand. An immobilized GST-tagged subunit of the receptor complex was utilized to assemble multi-subunit complexes in vitro and to study the phosphorylation events among subunits in the absence of extrinsic cell-derived kinases. The results revealed that (a) a low level of ligand-independent autophosphorylation occurs in the type I kinase; (b) a high level of autophosphorylation occurs in the type II kinase; (c) both the type III and type I subunits are trans-phosphorylated by the type II subunit; and (d) the presence of both type I and II kinases complexed with the type III subunit and dimeric TGF beta 1 ligand in a pentameric complex causes maximum phosphorylation of all three receptor subunits.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842749     DOI: 10.1007/bf02722961

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  42 in total

1.  Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction.

Authors:  M Laiho; M B Weis; J Massagué
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

2.  Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.

Authors:  W W He; M L Gustafson; S Hirobe; P K Donahoe
Journal:  Dev Dyn       Date:  1993-02       Impact factor: 3.780

3.  Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases.

Authors:  F Chen; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Monomeric activin A retains high receptor binding affinity but exhibits low biological activity.

Authors:  P Hüsken-Hindi; K Tsuchida; M Park; A Z Corrigan; J M Vaughan; W W Vale; W H Fischer
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

5.  Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis.

Authors:  M C Pepin; M Beauchemin; J Plamondon; M D O'Connor-McCourt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.

Authors:  J Xu; K McKeehan; K Matsuzaki; W L McKeehan
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

7.  A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain.

Authors:  T Brand; W R MacLellan; M D Schneider
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

8.  Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.

Authors:  L Attisano; J Cárcamo; F Ventura; F M Weis; J Massagué; J L Wrana
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  The types II and III transforming growth factor-beta receptors form homo-oligomers.

Authors:  Y I Henis; A Moustakas; H Y Lin; H F Lodish
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites.

Authors:  F López-Casillas; H M Payne; J L Andres; J Massagué
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  3 in total

1.  Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.

Authors:  A Taniguchi; K Matsuzaki; K Nakano; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

2.  Improved recovery of active radiolabeled TGFbeta1 by TGFbeta receptor type III affinity chromatography.

Authors:  K Nakano; A Taniguchi; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-05       Impact factor: 2.416

3.  Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development.

Authors:  M Matsushita; K Matsuzaki; M Date; T Watanabe; K Shibano; T Nakagawa; S Yanagitani; Y Amoh; H Takemoto; N Ogata; C Yamamoto; Y Kubota; T Seki; H Inokuchi; M Nishizawa; H Takada; T Sawamura; A Okamura; K Inoue
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.